Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
April 24, 2019 Off

Acerus to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference

By BusinessWire

TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP) announced today that Edward Gudaitis, President and Chief Executive Officer of Acerus, is scheduled to present an…

TC BioPharm Initiates Phase I Trial of Allogeneic Gamma Delta T Cell Therapy in Acute Myeloid Leukemia Patients
April 24, 2019 Off

TC BioPharm Initiates Phase I Trial of Allogeneic Gamma Delta T Cell Therapy in Acute Myeloid Leukemia Patients

By BusinessWire

The trial, for treatment of patients suffering from AcuteMyeloid Leukemia (AML), is being conducted at the Institute ofHematology and Blood Transfusion (ÚHKT) in Prague, Czech Republic.

Aptorum Group’s Smart Pharma announces launch of its asset backed Smart Pharma token (SMPT), supported by its computational repurposed drug discovery platform Smart-ACT™
April 24, 2019 Off

Aptorum Group’s Smart Pharma announces launch of its asset backed Smart Pharma token (SMPT), supported by its computational repurposed drug discovery platform Smart-ACT™

By BusinessWire

SMPT token holder will allow them to benefit from the inherent valuationgrowth of SPLP’s intellectual property portfolio

Aptorum Group Establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and Unmet Diseases
April 24, 2019 Off

Aptorum Group Establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and Unmet Diseases

By BusinessWire

Aptorum Group Limited has established new subsidiary group, Smart Pharma

Macrogen and Exosome Plus to Jointly Develop Exosome-based Diagnostic and Treatment Solutions
April 24, 2019 Off

Macrogen and Exosome Plus to Jointly Develop Exosome-based Diagnostic and Treatment Solutions

By BusinessWire

Exosome Plus will exclusively supplyits high-efficiency exosome isolation kit ‘Exo2DTM’ toMacrogen for one year.

Teva drops clinical development program for use of fremanezumab in episodic cluster headache
April 24, 2019 Off

Teva drops clinical development program for use of fremanezumab in episodic cluster headache

By BusinessWire

Teva is discontinuing the clinical developmentprogram for use of fremanezumab in cluster headaches.

Rexgenero Presents Update on Phase III Clinical Trials with REX-001, a Cell-based Therapy for Critical Limb Ischaemia
April 24, 2019 Off

Rexgenero Presents Update on Phase III Clinical Trials with REX-001, a Cell-based Therapy for Critical Limb Ischaemia

By BusinessWire

Rexgenero presented an update on its two Phase III SALAMANDER trials beingconducted across Europe for its lead development programme REX-001 totreat CLI in patients with diabetes.

Bicycle Therapeutics to Present Immune Oncology CD137 Data on Multivalent and Tumour-targeted Bispecific Bicycles at Peptides Congress
April 24, 2019 Off

Bicycle Therapeutics to Present Immune Oncology CD137 Data on Multivalent and Tumour-targeted Bispecific Bicycles at Peptides Congress

By BusinessWire

Punit Upadhyaya, Ph.D., SeniorScientist at Bicycle, will present at the 6th Annual PeptidesCongress in London.

April 24, 2019 Off

FSD Pharma Announces Share Exchange Transaction with Aura Health

By BusinessWire

– Intended Transaction positions FSD to establish distribution channel in Germany & Eurozone – TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/FSDDF?src=hash" target="_blank"gt;#FSDDFlt;/agt;–FSD Pharma Inc.…

April 24, 2019 Off

Aptorum Group Limited Announces Repurchase of USD13,500,000 Outstanding Convertible Bonds Due 2019

By BusinessWire

HONG KONG–(BUSINESS WIRE)–Aptorum Group Limited (NASDAQ: APM) (“Aptorum” or the “Company”), a pharmaceutical company focused on the development and commercialization…

Posts pagination

Previous 1 … 3,256 3,257 3,258 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine